West German Study Group
Clinical trials sponsored by West German Study Group, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a pill replace chemo for some breast cancer patients? Results expected Jul 2027 (estimated)
-
Could a pill replace chemo for some breast cancer patients?
Disease control OngoingThis study tests if a combination of ribociclib (a targeted pill) and hormone therapy works better than standard chemotherapy for women with a common type of early breast cancer (HR+/HER2-). About 1,684 women with intermediate-risk disease are taking part. The goal is to see whic…
Phase 3 • Sponsor: West German Study Group • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a targeted pill keep High-Risk breast cancer at bay?
Disease control OngoingThis phase 3 trial studies whether adding the drug abemaciclib (Verzenios) to standard hormone therapy helps prevent breast cancer from coming back in 1,260 women with high-risk, HR+/HER2- early breast cancer. Participants have already completed initial treatments like surgery or…
Phase 3 • Sponsor: West German Study Group • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC